A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of Medicines

Background: The development of a medicine is not only underpinned by good science but also by Quality DecisionMaking Practices (QDMPs). Indeed, it is important to ensure that all organisations involved in the lifecycle of medicines are aligning their practices in decision-making to the QDMPs to ensu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bujar, Magdalena, McAuslane, Neil, Walker, Stuart, Salek, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278608/
https://www.ncbi.nlm.nih.gov/pubmed/32610811
http://dx.doi.org/10.34172/ijhpm.2020.86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278608/
https://www.ncbi.nlm.nih.gov/pubmed/32610811
http://dx.doi.org/10.34172/ijhpm.2020.86

Ejemplares similares